Acecainide






70 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
51 17074894 The NapF protein of the Escherichia coli periplasmic nitrate reductase system: demonstration of a cytoplasmic location and interaction with the catalytic subunit, NapA. Microbiology (Reading) 2006 Nov 1
52 17161819 Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. Int Immunopharmacol 2007 Jan 4
53 17924112 Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study. Rheumatol Int 2008 Mar 1
54 18173918 Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes. Clin Exp Rheumatol 2007 Nov-Dec 2
55 18953652 Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells. Breast Cancer Res Treat 2009 Nov 6
56 19127062 Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. Dev Neurosci 2008 2
57 19414384 Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells. Anticancer Res 2009 Apr 3
58 20113495 A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes. Arthritis Res Ther 2010 10
59 21903092 Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation. Biochem Pharmacol 2011 Dec 1 17
60 21945668 Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression. Biochem Pharmacol 2011 Dec 15 3
61 24418856 TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels. Am J Surg Pathol 2014 Feb 1
62 27836674 Chondroprotective activity of N-acetyl phenylalanine glucosamine derivative on knee joint structure and inflammation in a murine model of osteoarthritis. Osteoarthritis Cartilage 2017 Apr 6
63 28154142 Dissecting the proton transport pathway in electrogenic Na<sup>+</sup>/H<sup>+</sup> antiporters. Proc Natl Acad Sci U S A 2017 Feb 14 1
64 29147265 CD99/MIC2 Constitutes a Differentiation Antigen of a Human Osteoblast Cell Line. World J Oncol 2011 Dec 1
65 29965477 [Start-Up and Regional Characteristics of a Pilot-scale Integrated PN-ANAMMOX Reactor]. Huan Jing Ke Xue 2018 Mar 8 1
66 30845766 Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and <i>N</i>-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats. Pharmaceutics 2019 Mar 6 6
67 31461854 <i>E. coli</i> Enterotoxin LtB Enhances Vaccine-Induced Anti-<i>H. pylori</i> Protection by Promoting Leukocyte Migration into Gastric Mucus via Inflammatory Lesions. Cells 2019 Aug 27 1
68 34363898 The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. Immunol Lett 2021 Nov 1
69 34452094 Effects of 1α,25-Dihydroxyvitamin D<sub>3</sub> on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach. Pharmaceutics 2021 Jul 25 1
70 34617854 Procainamide pharmacokinetics during extracorporeal membrane oxygenation. Perfusion 2021 Oct 7 1